Search Results - "Fagotti, A"
-
1
Author’s reply to correspondence on “Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes” by Mukurdipi Ray et al
Published in Annals of surgical oncology (01-08-2024)Get full text
Journal Article -
2
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept
Published in Gynecologic oncology (01-10-2015)“…Abstract Objective To develop an updated laparoscopy-based model to predict incomplete cytoreduction (RT > 0) in advanced epithelial ovarian cancer (AEOC),…”
Get full text
Journal Article -
3
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis
Published in Cancer treatment reviews (01-02-2020)“…•The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated.•Definitive chemoradiothherapy (CRT) is considered the standard…”
Get full text
Journal Article -
4
Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis
Published in Gynecologic oncology (01-04-2020)“…To compare survival outcomes and peri-operative complications in patients with advanced ovarian cancer with 1–10 mm residual disease (RD) at primary debulking…”
Get full text
Journal Article -
5
Comparison of minimally invasive surgery with laparotomic approach in the treatment of high risk endometrial cancer: A systematic review
Published in European journal of surgical oncology (01-05-2020)“…To analyze all published studies comparing minimally invasive surgery (MIS) with laparotomic one in the surgical treatment of high-risk endometrial cancer (EC)…”
Get full text
Journal Article -
6
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study)
Published in Scientific reports (09-01-2024)“…Current approach to identify BRCA 1/2 carriers in the general population is ineffective as most of the carriers remain undiagnosed. Radiomics is an emerging…”
Get full text
Journal Article -
7
Robotic Single-Port Platform in General, Urologic, and Gynecologic Surgeries: A Systematic Review of the Literature and Meta-analysis
Published in World journal of surgery (15-10-2019)“…Background Robotic platforms have recently acquired progressive importance in different surgical fields, such as urology, gynecology, and general surgery…”
Get full text
Journal Article -
8
Targeting the hallmarks of ovarian cancer: The big picture
Published in Gynecologic oncology (01-07-2016)“…Abstract Objective As a result of relevant achievements in the field of translational research, several active drugs and multiple biological targets are…”
Get full text
Journal Article -
9
Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study
Published in Gynecologic oncology (01-12-2019)“…The role of secondary cytoreductive surgery (SCS) in platinum-sensitive recurrent ovarian cancer (PSROC) is still controversial. We investigated the role of…”
Get full text
Journal Article -
10
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome)
Published in Annals of oncology (01-07-2007)“…Palmar-plantar erythrodysesthesia (PPE), also called hand-foot syndrome or hand-to-foot syndrome, is a distinctive and relatively frequent dermatologic toxic…”
Get full text
Journal Article -
11
Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer
Published in Annals of surgical oncology (01-04-2022)Get full text
Journal Article -
12
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Published in Annals of surgical oncology (01-05-2016)“…Background To analyze the 5- and 7-year survival outcomes for women with platinum-sensitive recurrent epithelial ovarian cancer (REOC) who underwent secondary…”
Get full text
Journal Article -
13
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience
Published in Gynecologic oncology (01-11-2013)“…Abstract Objective To evaluate the prognostic impact of routinely use of staging laparoscopy (S-LPS) in patients with primary advanced epithelial ovarian…”
Get full text
Journal Article -
14
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery
Published in Annals of surgical oncology (01-10-2021)“…Ovarian cancer is the most lethal of all gynecologic cancers. 1 Primary debulking surgery (PDS) with achievement of no residual tumor (RT, 0) still is the…”
Get full text
Journal Article -
15
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience
Published in BMC cancer (12-11-2019)“…The aim of this study was to assess the agreement rate between intraoperative evaluation (IOE) and final diagnosis (FD) in a series of surgically resected…”
Get full text
Journal Article -
16
Laparoscopic staging of apparent early stage ovarian cancer: Results of a large, retrospective, multi-institutional series
Published in Gynecologic oncology (01-12-2014)“…Abstract Objective The aim of this study is to analyze the safety, adequacy, perioperative and survival figures in a large series of laparoscopic staging of…”
Get full text
Journal Article -
17
The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation
Published in Facts, views & vision in ObGyn (01-03-2022)“…The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical…”
Get full text
Journal Article -
18
Obturator nerve regeneration using a genito-femoral graft placed only by fibrin sealant (Tisseel®)
Published in Gynecologic oncology (01-06-2019)“…•Obturator nerve injury is a rare complication of gynecologic surgery.•Nerve regeneration using a genito-femoral graft is a safe procedure.•Genito-femoral…”
Get full text
Journal Article -
19
Optimizing the number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma: A propensity-score matching analysis
Published in Gynecologic oncology (01-10-2021)“…Neoadjuvant chemotherapy and interval debulking surgery are now widely offered in ovarian cancer patients unsuitable for surgery; the number of preoperative…”
Get full text
Journal Article -
20
The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy
Published in International journal of gynecological cancer (01-01-2019)“…The aim of this retrospective multicenter study was to investigate the extent, feasibility, and outcomes of minimally invasive surgery at the time of interval…”
Get more information
Journal Article